Transmucosal Drug Delivery Devices Market Projected at $78.21 Billion by 2029 | Strategic Insights and Forecast Data
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
#How Has The Transmucosal Drug Delivery Devices Market Size Shifted, And What Is the Outlook Through 2034?_x000D_
The market for transmucosal drug delivery devices has seen significant expansion in the past few years. The market size is predicted to increase from $50.24 billion in 2024 to $55.04 billion in 2025, marking a compound annual growth rate (CAGR) of 9.6%. Factors such as the demand for speedy relief from angina, the efficacy of sublingual administration for quick blood absorption, the preference to avoid gastrointestinal degradation, the emergence of buccal tablets, and the requirement for non-invasive delivery of peptides and proteins have contributed to the growth during the historic period._x000D_
_x000D_
#How Much Will the Transmucosal Drug Delivery Devices Market Be Worth in 2029?#_x000D_
The market for transmucosal drug delivery devices is predicted to witness significant growth in the coming years, expanding to $78.21 billion by 2029 at a compound annual growth rate (CAGR) of 9.2%. The key drivers of this growth during the forecast period include advancements in smart drug delivery systems, the rising incidence of chronic illnesses, an increasing emphasis on personalized treatment, the growing medication demands of an aging population, and heightened awareness. Dominant trends anticipated for the forecast period encompass the broadening of therapeutic applications, the tailoring of drug delivery devices for personalized medicine, regulatory consent and guideline development, the emergence of new markets, the rise of environmentally friendly devices, and inventive formulations._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp_x000D_
_x000D_
#Which is the Largest Company in the Transmucosal Drug Delivery Devices Market?#_x000D_
Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd._x000D_
_x000D_
#What Are the Main Market Drivers in the Transmucosal Drug Delivery Devices Industry?#_x000D_
The increasing occurrence of chronic ailments is predicted to stimulate the expansion of the transmucosal drug delivery devices market in the future. Chronic diseases, typically slow-progressive and persistent conditions requiring constant medical intervention to manage symptoms and prevent complications, are on rise due to lifestyle changes, aging populations, environmental influences, challenges in healthcare systems, and urbanisation. Transmucosal drug delivery devices play a crucial role in chronic disease treatment by ensuring controlled and effective medication delivery, which in turn maintains therapeutic levels and boosts patient compliance. For example, a report from the Leukemia & Lymphoma Society (LLS), a charity organisation in the US, stated in August 2023 that every three minutes, someone in the US is diagnosed with leukemia, lymphoma, or myeloma. In 2023, around 184,720 individuals are anticipated to be diagnosed with these diseases, accounting for 9.4% of the projected 1,958,310 new cancer cases for that year. Consequently, the escalating prevalence of chronic diseases is fueling the growth of the transmucosal drug delivery devices market._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=16812&type=smp_x000D_
_x000D_
#How Is the Transmucosal Drug Delivery Devices Market Segments Structured?#_x000D_
The transmucosal drug delivery devices market covered in this report is segmented –_x000D_
_x000D_
1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery_x000D_
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types_x000D_
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications_x000D_
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals_x000D_
_x000D_
Subsegments:_x000D_
1) By Passive Transdermal Drug Delivery: Reservoir Systems, Matrix Systems, Micro-Needle Systems, Pressure-Sensitive Adhesive Systems_x000D_
2) By Active Transdermal Drug Delivery: Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microporation_x000D_
_x000D_
#What Strategic Trends Are Transforming the Transmucosal Drug Delivery Devices Market?#_x000D_
Leading firms in the transmucosal drug delivery device sector are pioneering innovative smart platforms, such as unique transdermal patch delivery systems, to augment drug absorption while improving patient adherence and ease of use. Transdermal patch delivery platforms essentially denote specialized technologies that are company-owned, used to dispense medications via the skin for controlled release and better therapeutic results. For example, in January 2024, Starton Therapeutics Inc, a biotech firm from the US, introduced STARSILON, its new exclusive transdermal patch delivery platform. It was launched to provide therapeutic delivery of complex-to-formulate APIs over prolonged periods. This enhances transdermal drug delivery choices for challenging active pharmaceutical ingredients (APIs) and improves therapeutic effectiveness through sustained delivery rates._x000D_
_x000D_
#Access The Full Report Here:#_x000D_
_x000D_
#Which Global Regions Offer the Highest Growth in the Transmucosal Drug Delivery Devices Market?#_x000D_
North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Purchase The Full Report Today:#_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16812_x000D_
_x000D_
#This Report Delivers Insight On: #_x000D_
1. How big is the transmucosal drug delivery devices market, and how is it changing globally?_x000D_
2. Who are the major companies in the transmucosal drug delivery devices market, and how are they performing?_x000D_
3. What are the key opportunities and risks in the transmucosal drug delivery devices market right now?_x000D_
4. Which products or customer segments are growing the most in the transmucosal drug delivery devices market?_x000D_
5. What factors are helping or slowing down the growth of the transmucosal drug delivery devices market?_x000D_
_x000D_
#About The Business Research Company:#_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 2071930708_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
